Efavirenz Plasma Concentrations in Obese, Human Immunodeficiency Virus (HIV)-Infected Subjects Save

Date Added
November 24th, 2015
PRO Number
Pro00048345
Researcher
Rachel Foster
Keywords
HIV / AIDS, Obesity
Summary

This prospective, single-site, pharmacokinetic, cohort study will examine the effects of obesity on plasma drug concentrations of efavirenz. Concentrations from two different times (random and 12-hour sample) will help form subject-specific pharmacokinetic drug curves to evaluate obesity's effects on efavirenz concentrations. Forty subjects (10 normal weight, 10 overweight, 10 obese, and 10 extremely obese) will be enrolled.

Institution
Palmetto
Recruitment Contact
Rachel Foster
(803) 434-2925
fosterr8@sccp.sc.edu

Change_preferences

-- OR --

Create_login